These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1477116)

  • 1. Three electrophoretic techniques comparison for des-gamma-carboxyprothrombin detection.
    Belle M; Guillaumont M; Leclercq M; Guinet R
    Appl Theor Electrophor; 1992; 3(2):73-6. PubMed ID: 1477116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Des-gamma-carboxyprothrombin detection by immunoblotting after polyacrylamide gel affinoelectrophoresis in human plasmas.
    Belle M; Hanss M; Guillaumont M; Leclercq M; Guinet R
    Electrophoresis; 1991 Apr; 12(4):294-7. PubMed ID: 2070784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of a new monoclonal antibody specific to human des-gamma-carboxyprothrombin in the presence of calcium ions. Application to the development of a sensitive ELISA-test.
    Belle M; Brebant R; Guinet R; Leclercq M
    J Immunoassay; 1995 May; 16(2):213-29. PubMed ID: 7629279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of des-gamma-carboxyprothrombin using staphylocoagulase. Application to the diagnosis of cellular hepatocarcinoma.
    Soulier JP; Gozin D; Lefrère JJ
    Haematologia (Budap); 1986; 19(1):3-12. PubMed ID: 2424813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Des-gamma-carboxyprothrombin (PIVKA II) and plasma vitamin K1 in newborns and their mothers.
    von Kries R; Shearer MJ; Widdershoven J; Motohara K; Umbach G; Göbel U
    Thromb Haemost; 1992 Oct; 68(4):383-7. PubMed ID: 1448768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of plasma abnormal prothrombin (des-gamma-carboxy prothrombin) in hepatobiliary malignancies and other diseases.
    Nakao A; Suzuki Y; Isshiki K; Kimura Y; Takeda S; Kishimoto W; Nonami T; Harada A; Takagi H
    Am J Gastroenterol; 1991 Jan; 86(1):62-6. PubMed ID: 1702578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acarboxyprothrombin in cord blood: congenital vitamin K deficiency in the newborn].
    Goldschmidt B; Verbényi M; Kovács I; Ilin E; Varga K; Német T
    Orv Hetil; 1988 Nov; 129(47):2513-7. PubMed ID: 3194135
    [No Abstract]   [Full Text] [Related]  

  • 9. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma.
    Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
    Am J Gastroenterol; 1990 Sep; 85(9):1149-54. PubMed ID: 1697141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
    Nakao A; Taniguchi K; Inoue S; Harada A; Nonami T; Watanabe K; Takagi H
    Semin Surg Oncol; 1996; 12(3):160-3. PubMed ID: 8727604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein C level at birth.
    Polack B; Pouzol P; Amiral J; Kolodie L
    Thromb Haemost; 1984 Oct; 52(2):188-91. PubMed ID: 6549231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four methods compared for measuring des-carboxy-prothrombin (PIVKA-II).
    Widdershoven J; van Munster P; De Abreu R; Bosman H; van Lith T; van der Putten-van Meyel M; Motohara K; Matsuda I
    Clin Chem; 1987 Nov; 33(11):2074-8. PubMed ID: 3315304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
    Strople J; Lovell G; Heubi J
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Des-gamma-carboxyprothrombin expression in cancer and/or non-cancer liver tissues: association with survival of patients with resectable hepatocellular carcinoma.
    Tang W; Kokudo N; Sugawara Y; Guo Q; Imamura H; Sano K; Karako H; Qu X; Nakata M; Makuuchi M
    Oncol Rep; 2005 Jan; 13(1):25-30. PubMed ID: 15583797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of abnormal prothrombin-crossed immunoelectrophoresis in fetuses during the second trimester of pregnancy.
    Forestier F; Daffos F; Rainaut M
    Thromb Haemost; 1985 Aug; 54(2):560. PubMed ID: 4082098
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma.
    Nomura F; Ishijima M; Kuwa K; Tanaka N; Nakai T; Ohnishi K
    Am J Gastroenterol; 1999 Mar; 94(3):650-4. PubMed ID: 10086646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma.
    Uehara S; Gotoh K; Handa H; Tomita H; Senshuu M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1545-52. PubMed ID: 16174072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Watanabe K; Magario N; Yokoo T; Naraki T
    Cancer; 1999 Feb; 85(4):812-8. PubMed ID: 10091758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation assays as diagnostic markers of hepatocellular carcinoma.
    Lefrère JJ; Conard J; Mavier P; Bettan L; Beaugrand M; Gozin D; Lerable J; Dhumeaux D; Samama M
    Thromb Haemost; 1988 Dec; 60(3):468-70. PubMed ID: 2467402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.